中间神经神经痛中间神经切断术后无痛与疼痛控制生存:单机构回顾
该单机构回顾性研究分析2002至2016年15例中间神经神经痛(NIN)患者,14例接受中间神经切断术,其中8例合并三叉神经痛。术后13例即刻疼痛缓解,总体疼痛复发率42%(6/14),中位无痛生存4.82年±14.85个月,中位疼痛控制生存6.22年±15.78个月。作者结论:中间神经切断术无永久性面肌无力或耳聋等重大并发症,在联合其他术式时有效,单独实施则无效。
要点
- 14例中间神经切断术中13例术后即刻疼痛缓解,总体疼痛复发率42%(6/14)。
- 中位无痛生存4.82年±14.85个月,中位疼痛控制生存6.22年±15.78个月。
- 单独接受中间神经切断术的4例孤立性NIN患者报告疼痛同术前或更差。
核心结论
- 中间神经切断术未产生永久性面肌无力或耳聋等重大并发症,在联合其他术式时对患者有效。
- 术后患者获得4.8年无痛生存和6.2年较术前疼痛减轻的生存。
- 单独实施中间神经切断术无效。
- NIN的病理生理学尚未完全明确,神经血管压迫在该综合征中似乎仅起次要作用,且与三叉神经痛高度重叠。
研究设计与样本
- 单机构回顾性病历回顾与患者调查,纳入2002至2016年由两位术者行显微外科手术的15例NIN患者。
- 14例接受中间神经切断术,其中8例合并三叉神经痛。
- 通过病历回顾和电话访谈使用改良面部疼痛与生活质量问卷确定无痛生存,以Kaplan-Meier曲线表示。
主要发现
- 5例存在可见的中间神经神经血管压迫,多数为小脑前下动脉压迫。
- 最常见的术后主诉为头晕与眩晕、复视、耳闷、耳鸣和暂时性面神经麻痹。
- 14例中13例报告术后即刻疼痛缓解。
- 平均随访6.41年(范围8个月至14.5年)。
- 任何疼痛总体复发率42%(6/14);4例接受单纯中间神经切断术的孤立性NIN患者在最長随访时报告疼痛同术前或更差。
关键数值与推荐
- 中位无痛生存4.82年±14.85个月。
- 中位疼痛控制生存6.22年±15.78个月。
- 任何疼痛总体复发率42%(6/14)。
- 14例中13例术后即刻疼痛缓解。
临床怎么用
- 作者认为中间神经切断术在联合其他术式时有效,单独实施则无效。
- 原文未据此给出其他推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Nervus intermedius neuralgia (NIN) or geniculate neuralgia is a rare facial pain condition consisting of sharp, lancinating pain deep in the ear and can occur alongside trigeminal neuralgia (TN). Studies on the clinical presentation, intraoperative findings, and ultimately postoperative outcomes are extremely limited. The aim of this study was to examine the clinical presentation and surgical findings, and determine pain-free survival after sectioning of the nervus intermedius (NI). METHODS: The authors conducted a retrospective chart review and survey of patients who were diagnosed with NIN at one institution and who underwent neurosurgical interventions. Pain-free survival was determined through chart review and phone interviews using a modified facial pain and quality of life questionnaire and represented as Kaplan-Meier curves. RESULTS: The authors found 15 patients with NIN who underwent microsurgical intervention performed by two surgeons from 2002 to 2016 at a single institution. Fourteen of these patients underwent sectioning of the NI, and 8 of 14 had concomitant TN. Five patients had visible neurovascular compression (NVC) of the NI by the anterior inferior cerebellar artery in most cases where NVC was found. The most common postoperative complaints were dizziness and vertigo, diplopia, ear fullness, tinnitus, and temporary facial nerve palsy. Thirteen of the 14 patients reportedly experienced pain relief immediately after surgery. The mean length of follow-up was 6.41 years (range 8 months to 14.5 years). Overall recurrence of any pain was 42% (6 of 14), and 4 patients (isolated NIN that received NI sectioning alone) reported their pain was the same or worse than before surgery at longest follow-up. The median pain-free survival was 4.82 years ± 14.85 months. The median pain-controlled survival was 6.22 years ± 15.78 months. CONCLUSIONS: In this retrospective review, sectioning of the NI produced no major complications, such as permanent facial weakness or deafness, and was effective for patients when performed in addition to other procedures. After sectioning of the NI, patients experienced 4.8 years pain free and experienced 6.2 years of less pain than before surgery. Alone, sectioning of the NI was not effective. The pathophysiology of NIN is not entirely understood. It appears that neurovascular compression plays only a minor role in the syndrome and there is a high degree of overlap with TN.
引用
- Holste KG, Hardaway FA, Raslan AM, et al. Pain-free and pain-controlled survival after sectioning the nervus intermedius in nervus intermedius neuralgia: a single-institution review. J Neurosurg. 2018. PMID: 30117769. doi:10.3171/2018.3.JNS172495
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。